Phenominer

	Submit Data \| Help \| Video Tutorials \| News \| Publications \| Download \| REST API \| Citing RGD \| Contact
	Search RGD Grant Resources Citing RGD About Us Contact Us Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) (beta) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer) Overgo Probe Designer Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease Find Models new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive Pathways Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
	Advanced Search (OLGA)

Phenominer Database Results (12 results)

How to display a graph

Strain	Phenotype	Conditions	Study	Experiment Name	Sex	Age	# of Animals	Value	Units	SEM	SD	Method	Method Duration	Post Insult Time Value	Method Notes	Clinical Measurement Notes	Record ID	Study ID
WF.BBDR-(D4Rat96-D4Rat44)/Wor	percentage of study population developing type 1 diabetes mellitus during a period of time	anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g)	Mordes JP, et al., Diabetes 2002 Nov;51(11):3254-62.	glucose metabolism trait	not specified	68 days-72 days	12	58.0	%			blood glucose analysis	0	0	anti-ART2.1mAB and poly I:C		66157	714
WF.BBDR-(D4Rat16-D4Got39)/Wor	percentage of study population developing type 1 diabetes mellitus during a period of time	anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g)	Mordes JP, et al., Diabetes 2002 Nov;51(11):3254-62.	glucose metabolism trait	not specified	68 days-72 days	4	0.0	%			blood glucose analysis	0	0	anti-ART2.1mAB and poly I:C		66160	714
WF.BBDR-(D4Arb29-D4Rat265)/Wor	post-insult time to onset of diabetes mellitus	anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g)	Mordes JP, et al., Diabetes 2002 Nov;51(11):3254-62.	glucose metabolism trait	not specified	68 days-72 days	5	30.0	d			blood glucose analysis	0.0	0	anti-ART2.1mAB and poly I:C		66162	714
WF.BBDR-(D4Rat96-D4Rat44)/Wor	post-insult time to onset of diabetes mellitus	anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g)	Mordes JP, et al., Diabetes 2002 Nov;51(11):3254-62.	glucose metabolism trait	not specified	68 days-72 days	12	24.0	d			blood glucose analysis	0.0	0	anti-ART2.1mAB and poly I:C		66158	714
WF.BBDR-(D4Arb29-D4Rat44)/Wor	post-insult time to onset of diabetes mellitus	anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g)	Mordes JP, et al., Diabetes 2002 Nov;51(11):3254-62.	glucose metabolism trait	not specified	68 days-72 days	18	20.0	d			blood glucose analysis	0.0	0	anti-ART2.1mAB and poly I:C		66165	714
WF.BBDR-(D4Arb29-D4Rat96)/Wor	post-insult time to onset of diabetes mellitus	anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g)	Mordes JP, et al., Diabetes 2002 Nov;51(11):3254-62.	glucose metabolism trait	not specified	68 days-72 days	10	30.0	d			blood glucose analysis	0.0	0	anti-ART2.1mAB and poly I:C		66164	714
WF.BBDR-(D4Arb29-D4Rat265)/Wor	percentage of study population developing type 1 diabetes mellitus during a period of time	anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g)	Mordes JP, et al., Diabetes 2002 Nov;51(11):3254-62.	glucose metabolism trait	not specified	68 days-72 days	5	40.0	%			blood glucose analysis	0.0	0	anti-ART2.1mAB and poly I:C		66161	714
WF.BBDR-(D4Got39-D4Rat44)/Wor	percentage of study population developing type 1 diabetes mellitus during a period of time	anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g)	Mordes JP, et al., Diabetes 2002 Nov;51(11):3254-62.	glucose metabolism trait	not specified	68 days-72 days	10	30.0	%			blood glucose analysis	0.0	0	anti-ART2.1mAB and poly I:C	incidence of experimental diabetes mellitus	66154	714
WF.BBDR-(D4Got39-D4Rat44)/Wor	post-insult time to onset of diabetes mellitus	anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g)	Mordes JP, et al., Diabetes 2002 Nov;51(11):3254-62.	glucose metabolism trait	not specified	68 days-72 days	10	17.0	d			blood glucose analysis	0.0	0	anti-ART2.1mAB and poly I:C	onset of experimental diabetes mellitus	66156	714
WF.BBDR-(D4Arb29-D4Rat44)/Wor	percentage of study population developing type 1 diabetes mellitus during a period of time	anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g)	Mordes JP, et al., Diabetes 2002 Nov;51(11):3254-62.	glucose metabolism trait	not specified	68 days-72 days	18	39.0	%			blood glucose analysis	0	0	anti-ART2.1mAB and poly I:C		66159	714
WF.BBDR-(D4Arb29-D4Rat96)/Wor	percentage of study population developing type 1 diabetes mellitus during a period of time	anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g)	Mordes JP, et al., Diabetes 2002 Nov;51(11):3254-62.	glucose metabolism trait	not specified	68 days-72 days	10	20.0	%			blood glucose analysis	0.0	0	anti-ART2.1mAB and poly I:C		66163	714
WF.BBDR-(D4Got51-D4Rat44)/Wor	percentage of study population developing type 1 diabetes mellitus during a period of time	anti-RT6.1 antibody (1 ml) and Poly I:C (2.5 ug/g)	Mordes JP, et al., Diabetes 2002 Nov;51(11):3254-62.	glucose metabolism trait	not specified	68 days-72 days	12	0.0	%			blood glucose analysis	0	0	anti-ART2.1mAB and poly I:C		66155	714

Contact Us | About Us | Jobs at RGD

© Bioinformatics Program, HMGC at the Medical College of Wisconsin

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.
NHLBI Logo